Stocks and Investing Stocks and Investing
Wed, August 7, 2024

Danielle Antalffy Maintained (TMCI) at Hold with Increased Target to $7 on, Aug 7th, 2024


Published on 2024-10-28 13:20:08 - WOPRAI, Danielle Antalffy
  Print publication without navigation


Danielle Antalffy of UBS, Maintained "Treace Medical Concepts, Inc." (TMCI) at Hold with Increased Target from $6.5 to $7 on, Aug 7th, 2024.

Danielle has made no other calls on TMCI in the last 4 months.



There are 4 other peers that have a rating on TMCI. Out of the 4 peers that are also analyzing TMCI, all agree with Danielle's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Drew Ranieri of "Morgan Stanley" Maintained at Hold with Increased Target to $8 on, Monday, July 15th, 2024
  • Rick Wise of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $6 on, Wednesday, May 8th, 2024
  • Robbie Marcus of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $8 on, Wednesday, May 8th, 2024
  • Ryan Zimmerman of "BTIG" Downgraded from Strong Buy to Hold on, Wednesday, May 8th, 2024
Contributing Sources